Effect Of Pathyadi Kwatha In Dysfunctional Uterine Bleeding(Asrigdara)
Phase 3
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
- Registration Number
- CTRI/2023/10/058721
- Lead Sponsor
- Dr Komal T Gayakwad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Pratyatma lakshana of Asrigdara and DUB.
Asrigdara-Artava deergha kala Pravritti, Artava Ati Pravritti, Anruta kala Pravritti.
Exclusion Criteria
1.K/C/O – Diabetes mellitus, hypertension, tuberculosis.
2.Patient using intra uterine contraceptive device
3.K/C/O-Coagulation disorders
4.Patient with severe anemia HB% below 8 gms
5.K/C/O- Any pelvic pathology
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect of trial drug on improvement in the symptoms of Asrigdara(DUB).Timepoint: 4th day of menses, 10th day for three consecutive cycle
- Secondary Outcome Measures
Name Time Method Safety of the trial drug & Adverse Drug reaction & Aggravation in the symptoms of Asrigdara(DUB)Timepoint: 4th day of menses, 10th day for three consecutive cycle